.
MergerLinks Header Logo

New Deal


Announced

DCC Healthcare to acquire Amerilab Technologies for $85m.

Financials

Edit Data
Transaction Value£72m
Consideration TypeContingent Deferred Consideration, Cash
Capital Owned-
Capital Bid For100%
EV/Sales1.4x
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Friendly

active pharmaceutical ingredients

Pending

Pharmaceuticals

Private

drug manufacturing

biopharmaceuticals

Majority

United States

Acquisition

Single Bidder

Synopsis

Edit

DCC Health & Beauty Solutions, a manufacturer of nutritional, cosmetic and pharmaceutical products, agreed to acquire Amerilab Technologies, a specialist provider of contract manufacturing and related services in effervescent nutritional products, for $85m. "The acquisition of Amerilab significantly enhances our existing presence in the US market. We continue to be excited by the significant opportunities for organic and acquisitive growth in this market. We believe this market will benefit from current events as consumers are likely to be increasingly conscious of their health and wellbeing," Donal Murphy CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US